Team:EPF Lausanne/Calendar/1 August 2013

From 2013.igem.org

(Difference between revisions)
(Created page with "{{Template:EPFL2013Header}} {{Template:EPFL2013Footer}}")
 
(4 intermediate revisions not shown)
Line 1: Line 1:
{{Template:EPFL2013Header}}
{{Template:EPFL2013Header}}
 +
<font size = "4">Cell Surface Display</font>
 +
 +
''Gibson Assembly ''
 +
<br> -We did the DpnI digestion of our previous PCR products (streptavidin dead and INP_construct) to remove any carry over of the original plasmids.
 +
<br>-Gibson Assembly from the DpnI digested products (see under protocols).
 +
<br> -Gel electrophoresis to verify the Gibson product.
 +
<BR>
 +
 +
 +
<font size = "4">Nanoparticles</font>
 +
 +
''Making nanoparticles 1st try'' <br>
 +
We did the second cross-linking step with glutaraldehyde of the GPs+dye.
 +
{{Template:EPFL2013Footer}}
{{Template:EPFL2013Footer}}

Latest revision as of 14:40, 3 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Cell Surface Display

Gibson Assembly
-We did the DpnI digestion of our previous PCR products (streptavidin dead and INP_construct) to remove any carry over of the original plasmids.
-Gibson Assembly from the DpnI digested products (see under protocols).
-Gel electrophoresis to verify the Gibson product.


Nanoparticles

Making nanoparticles 1st try
We did the second cross-linking step with glutaraldehyde of the GPs+dye.